Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial.


Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
01 2021
Historique:
received: 20 09 2020
revised: 27 10 2020
accepted: 27 10 2020
pubmed: 7 11 2020
medline: 19 11 2021
entrez: 6 11 2020
Statut: ppublish

Résumé

To assess the effect of a fermented rice-flour obtained from Lactobacillus paracasei CBA L74 in managing infants with moderate to severe atopic dermatitis. Infants with moderate to severe atopic dermatitis, aged 6-36 months, were randomly assigned to receive once-daily consumption of rice flour containing heat-killed probiotic Lactobacillus paracasei CBA L74 or placebo for 12 weeks as supplementary approach to topical treatment. Primary outcome was SCORAD index change from baseline to 12 weeks; secondary outcomes were gut microbiota composition, as evaluated by the analysis of fecal samples, and serum cytokines at baseline and at the end of the intervention period in both groups, and steroid usage over the treatment period and one month after stopping it. V3-V4 region of the 16S ribosomal RNA gene was sequenced to evaluate changes in the gut microbiota. SCORAD index decreased over the treatment period in both groups. The difference in the SCORAD change was -2.1 (-5.5 to 1.3; p = 0.223) for the experimental vs. the placebo group, not reaching the minimal clinical difference of 8.7 units. The use of topical steroids, measured as finger tips units, decreased from 4 to 16 weeks, in both groups; the reduction was significantly higher in experimental than in placebo group (p value from Wilcoxon rank sum test = 0.031). No significant differences were observed for cytokines levels between groups. The composition of gut microbiota at the phylum and class taxonomic levels resulted very similar, at baseline and after intervention, in both groups. Similarly, no significant differences were observed in the relative abundance of bacterial genera between groups. In conclusion, though the heat-killed Lactobacillus paracaseiwas not proved to be effective in reducing the severity of atopic dermatitis, it showed a steroid sparing effect the value of which needs to be further investigated.

Identifiants

pubmed: 33157233
pii: S1043-6618(20)31592-9
doi: 10.1016/j.phrs.2020.105284
pii:
doi:

Substances chimiques

Cytokines 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105284

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Enza D'Auria (E)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy. Electronic address: enza.dauria@unimi.it.

Simona Panelli (S)

Pediatric Clinical Research Center "Invernizzi", University of Milan, Milan, Italy.

Luisa Lunardon (L)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Massimo Pajoro (M)

Pediatric Clinical Research Center "Invernizzi", University of Milan, Milan, Italy.

Laura Paradiso (L)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Silvia Beretta (S)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Cristian Loretelli (C)

Pediatric Clinical Research Center "Invernizzi", University of Milan, Milan, Italy.

Diego Tosi (D)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Matteo Perini (M)

Pediatric Clinical Research Center "Invernizzi", University of Milan, Milan, Italy.

Giorgio Bedogni (G)

Clinical Epidemiology Unit, Liver Research Center, Basovizza, Trieste, Italy.

Ahmed Abdelsalam (A)

Pediatric Clinical Research Center Fondazione Romeo e Enrica Invernizzi, Department of Biomedical and Clinical Science L. Sacco, University of Milan, Milan.

Paolo Fiorina (P)

Pediatric Clinical Research Center Fondazione Romeo e Enrica Invernizzi, Department of Biomedical and Clinical Science L. Sacco, University of Milan, Milan; Nephrology Division, Boston Children's Hospital, Harvard Medical School, Enders Building 5th Floor Room EN511, 300 Longwood Ave, Boston, MA, USA.

Claudio Bandi (C)

Pediatric Clinical Research Center Fondazione Romeo e Enrica Invernizzi, Department of Biomedical and Clinical Science L. Sacco, University of Milan, Milan.

Gian Vincenzo Zuccotti (GV)

Department of Paediatrics, Vittore Buzzi Children's Hospital, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH